Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideyuki Abe

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Cancer Immunology, Immunotherapy : CII|February 26, 2011
Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinomaNobutaka Furuya, Takao Kamai, Hiromichi Shirataki, et al.
Cancer Science|May 20, 2021
Single nucleotide variants of succinate dehydrogenase A gene in renal cell carcinomaTakao Kamai, Satoru Higashi, Satoshi Murakami, et al.
Oncotargets and Therapy|March 15, 2014
Axitinib for preoperative downstaging of renal cell carcinoma with sarcomatoid differentiation and direct invasion of the duodenum and inferior vena cava: a case reportHideo Yuki, Takao Kamai, Keiichi Kubota, et al.
Oncotarget|July 10, 2018
Increased Nrf2 expression by renal cell carcinoma is associated with postoperative chronic kidney disease and an unfavorable prognosisHideo Yuki, Takao Kamai, Satoshi Murakami, et al.
International Journal of Clinical Oncology|November 4, 2017
Significance of sarcopenia as a prognostic factor for metastatic urothelial carcinoma patients treated with systemic chemotherapyHideyuki Abe, Kohei Takei, Toshitaka Uematsu, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|October 6, 2018
Insulinoma-associated protein 1 expression in pancreatic neuroendocrine tumours in endoscopic ultrasound-guided fine-needle aspiration cytology: An analysis of 14 patientsYorihiko Takase, Yoshiki Naito, Yoshinobu Okabe, et al.
Cancer Cytopathology|October 30, 2013
Fixation effect of SurePath preservative fluids using epidermal growth factor receptor mutation-specific antibodies for immunocytochemistryAkihiko Kawahara, Tomoki Taira, Hideyuki Abe, et al.
Journal of Neuropathology and Experimental Neurology|April 17, 2019
Expression of GLUT1 in Pseudopalisaded and Perivascular Tumor Cells Is an Independent Prognostic Factor for Patients With GlioblastomasSatoru Komaki, Yasuo Sugita, Takuya Furuta, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|January 12, 2020
Expression of the ghrelin/growth hormone secretagogue receptor axis and its functional role in promoting tumor growth in primary central nervous system lymphomasHiroko Muta, Yasuo Sugita, Takuya Furuta, et al.
Communications Biology|March 8, 2020
NDRG1 activates VEGF-A-induced angiogenesis through PLCγ1/ERK signaling in mouse vascular endothelial cellsKosuke Watari, Tomohiro Shibata, Hideaki Fujita, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Cancer Immunology, Immunotherapy : CII|February 26, 2011
Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinomaNobutaka Furuya, Takao Kamai, Hiromichi Shirataki, et al.
Cancer Science|May 20, 2021
Single nucleotide variants of succinate dehydrogenase A gene in renal cell carcinomaTakao Kamai, Satoru Higashi, Satoshi Murakami, et al.
Oncotargets and Therapy|March 15, 2014
Axitinib for preoperative downstaging of renal cell carcinoma with sarcomatoid differentiation and direct invasion of the duodenum and inferior vena cava: a case reportHideo Yuki, Takao Kamai, Keiichi Kubota, et al.
Oncotarget|July 10, 2018
Increased Nrf2 expression by renal cell carcinoma is associated with postoperative chronic kidney disease and an unfavorable prognosisHideo Yuki, Takao Kamai, Satoshi Murakami, et al.
International Journal of Clinical Oncology|November 4, 2017
Significance of sarcopenia as a prognostic factor for metastatic urothelial carcinoma patients treated with systemic chemotherapyHideyuki Abe, Kohei Takei, Toshitaka Uematsu, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|October 6, 2018
Insulinoma-associated protein 1 expression in pancreatic neuroendocrine tumours in endoscopic ultrasound-guided fine-needle aspiration cytology: An analysis of 14 patientsYorihiko Takase, Yoshiki Naito, Yoshinobu Okabe, et al.
Cancer Cytopathology|October 30, 2013
Fixation effect of SurePath preservative fluids using epidermal growth factor receptor mutation-specific antibodies for immunocytochemistryAkihiko Kawahara, Tomoki Taira, Hideyuki Abe, et al.
Journal of Neuropathology and Experimental Neurology|April 17, 2019
Expression of GLUT1 in Pseudopalisaded and Perivascular Tumor Cells Is an Independent Prognostic Factor for Patients With GlioblastomasSatoru Komaki, Yasuo Sugita, Takuya Furuta, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|January 12, 2020
Expression of the ghrelin/growth hormone secretagogue receptor axis and its functional role in promoting tumor growth in primary central nervous system lymphomasHiroko Muta, Yasuo Sugita, Takuya Furuta, et al.
Communications Biology|March 8, 2020
NDRG1 activates VEGF-A-induced angiogenesis through PLCγ1/ERK signaling in mouse vascular endothelial cellsKosuke Watari, Tomohiro Shibata, Hideaki Fujita, et al.
Pageof 9